Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in J Pediatr Hematol Oncol

Retrieve available abstracts of 104 articles:
HTML format
Text format



Single Articles


    November 2017
  1. MOSAKHANI N, Missiry ME, Vakkila E, Knuutila S, et al
    Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017;39:585-588.
    PubMed     Text format     Abstract available


  2. DANG BN, De Oliveira S, Bowles L, Moore TB, et al
    Isolated Testicular Recurrence of AML in Patients With Chronic GVHD >1 Year Following Allogeneic Stem Cell Transplant.
    J Pediatr Hematol Oncol. 2017;39:e423-e425.
    PubMed     Text format     Abstract available


  3. SHAUKAT H, O'Mara J, Neier M
    A Pediatric Case of Persistent Thrombocytopenia in a Patient Who Developed All.
    J Pediatr Hematol Oncol. 2017;39:e512-e514.
    PubMed     Text format     Abstract available


  4. EROGLU N, Bahadir A, Erduran E
    A Case of ALL Developing Posterior Reversible Encephalopathy Secondary to Hyponatremia.
    J Pediatr Hematol Oncol. 2017;39:e476-e478.
    PubMed     Text format     Abstract available


    October 2017
  5. HILL R, Hamby T, Bashore L, Rapisand S, et al
    Early Nutrition Intervention Attenuates Weight Gain for Pediatric Acute Lymphoblastic Leukemia Patients in Maintenance Therapy.
    J Pediatr Hematol Oncol. 2017 Oct 17. doi: 10.1097/MPH.0000000000000975.
    PubMed     Text format     Abstract available


  6. VATSAYAN A, Talati R, Nagle K, Cabral L, et al
    Complete Resolution of Lymphoid Interstitial Pneumonia in a Patient With Juvenile Myelomonocytic Leukemia Treated With Allogeneic Bone Marrow Transplant: Killing 2 Birds With 1 Stone.
    J Pediatr Hematol Oncol. 2017 Oct 11. doi: 10.1097/MPH.0000000000000977.
    PubMed     Text format     Abstract available


  7. ERKER C, Huppler AR, Walsh TJ, McCormick ME, et al
    Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Oct 5. doi: 10.1097/MPH.0000000000000985.
    PubMed     Text format     Abstract available


  8. CHENG G, Ozgonenel B, Bhambhani K, Kapur G, et al
    Recurrent Atypical Hemolytic Uremic Syndrome in Children With Acute Lymphoblastic Leukemia Undergoing Maintenance Chemotherapy.
    J Pediatr Hematol Oncol. 2017 Oct 4. doi: 10.1097/MPH.0000000000000987.
    PubMed     Text format     Abstract available


  9. ESTEPP JH, Smeltzer MP, Kang G, Howard SC, et al
    Safe Use of Low-Molecular-weight Heparin in Pediatric Acute Lymphoblastic Leukemia and Lymphoma Around Lumbar Punctures.
    J Pediatr Hematol Oncol. 2017 Oct 4. doi: 10.1097/MPH.0000000000000988.
    PubMed     Text format     Abstract available


  10. KIM MJ, Nasr A, Kabir B, de Nanassy J, et al
    Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review.
    J Pediatr Hematol Oncol. 2017;39:528-537.
    PubMed     Text format     Abstract available


  11. KIZILOCAK H, Dikme G, Ozdemir N, Kurugoglu S, et al
    Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
    J Pediatr Hematol Oncol. 2017;39:e373-e376.
    PubMed     Text format     Abstract available


  12. CHEYUO C, Radwan W, Ahn J, Gyure K, et al
    Biallelic PMS2 Mutation and Heterozygous DICER1 Mutation Presenting as Constitutional Mismatch Repair Deficiency With Corpus Callosum Agenesis: Case Report and Review of Literature.
    J Pediatr Hematol Oncol. 2017;39:e381-e387.
    PubMed     Text format     Abstract available


    September 2017
  13. FELICE MS, Rossi JG, Alonso CN, Rubio P, et al
    Second Neoplasms in Children Following a Treatment for Acute Leukemia and/or Lymphoma: 29 Years of Experience in a Single Institution in Argentina.
    J Pediatr Hematol Oncol. 2017 Sep 22. doi: 10.1097/MPH.0000000000000971.
    PubMed     Text format     Abstract available


  14. DEGNIN M, Agarwal A, Tarlock K, Meshinchi S, et al
    Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug Screens.
    J Pediatr Hematol Oncol. 2017 Sep 12. doi: 10.1097/MPH.0000000000000946.
    PubMed     Text format     Abstract available


  15. WHITTLE SB, Punia JN, Lopez-Terrada D, Gaikwad A, et al
    Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma.
    J Pediatr Hematol Oncol. 2017 Sep 8. doi: 10.1097/MPH.0000000000000956.
    PubMed     Text format     Abstract available


    August 2017
  16. MARTINEZ-ROMERA I, Villa M, Areal P, Rodrigo E, et al
    Hemophagocytic Lymphohistiocytosis: A Dangerous Intruder in Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Aug 30. doi: 10.1097/MPH.0000000000000932.
    PubMed     Text format     Abstract available


  17. MCNEW BR, Darbro BW, Ma D, Gordon DJ, et al
    Development of Secondary Acute Myeloid Leukemia in a Pediatric Patient Concurrently Receiving Primary Therapy for Ewing Sarcoma.
    J Pediatr Hematol Oncol. 2017 Aug 14. doi: 10.1097/MPH.0000000000000924.
    PubMed     Text format     Abstract available


  18. OLCAY L, Serteser M, Kolay M, Balci HF, et al
    The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress.
    J Pediatr Hematol Oncol. 2017;39:425-439.
    PubMed     Text format     Abstract available


  19. LASHKARI HP, Fernandes N, Alva K, Rai S, et al
    Central Nervous System Fungal Infection and Acute Lymphoblastic Leukemia in Children: What is the Optimal Duration of Antifungal Therapy?
    J Pediatr Hematol Oncol. 2017;39:e312-e317.
    PubMed     Text format     Abstract available


  20. KAYILIOGLU H, Kocak U, Kan Karaer D, Percin EF, et al
    Association of CYP3A5 Expression and Vincristine Neurotoxicity in Pediatric Malignancies in Turkish Population.
    J Pediatr Hematol Oncol. 2017;39:458-462.
    PubMed     Text format     Abstract available


    July 2017
  21. SCHRAW JM, Henson AT, Scheurer ME, Forman MR, et al
    The Associations of Height-for-Age, Weight-for-Age, and Weight-for-Height With Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jul 20. doi: 10.1097/MPH.0000000000000874.
    PubMed     Text format     Abstract available


  22. GERVASINI G, de Murillo SG, Jimenez M, de la Maya MD, et al
    Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy.
    J Pediatr Hematol Oncol. 2017 Jul 17. doi: 10.1097/MPH.0000000000000908.
    PubMed     Text format     Abstract available


  23. DE LEONARDIS F, Perillo T, Daniele RM, Santoro N, et al
    Cytomegalovirus Cavitary Pneumonia in Nontransplant Pediatric Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2017 Jul 10. doi: 10.1097/MPH.0000000000000901.
    PubMed     Text format     Abstract available


  24. IQBAL A, Weinstein J, Angelova V, Dighe D, et al
    A Rare Case of Spontaneous Remission of Terminal Deoxynucleotidyl Transferase Negative B-acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jul 3. doi: 10.1097/MPH.0000000000000906.
    PubMed     Text format     Abstract available


  25. SHIGEMURA T, Motobayashi M, Matsuda K, Shimodaira T, et al
    Acute Myeloid Leukemia in a Patient With X-linked Severe Combined Immunodeficiency.
    J Pediatr Hematol Oncol. 2017 Jul 3. doi: 10.1097/MPH.0000000000000892.
    PubMed     Text format     Abstract available


  26. SCHRAW JM, Henson AT, Scheurer ME, Forman MR, et al
    The Associations of Height-for-Age, Weight-for-Age, and Weight-for-Height With Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017;39:376-381.
    PubMed     Text format     Abstract available


    June 2017
  27. TUFEKCI O, Yilmaz Bengoa S, Erdem M, Oren H, et al
    Induction Failure in Acute Leukemia or Parvovirus B19 Infection?
    J Pediatr Hematol Oncol. 2017 Jun 29. doi: 10.1097/MPH.0000000000000866.
    PubMed     Text format     Abstract available


    May 2017
  28. GLASSER CL, Lee A, Eslin D, Marks L, et al
    Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse.
    J Pediatr Hematol Oncol. 2017 May 29. doi: 10.1097/MPH.0000000000000868.
    PubMed     Text format     Abstract available


  29. MOOIJ CF, van Alfen-van der Velden JAEM, Netea-Maier RT, Ten Broek R, et al
    Pancytopenia and Hypothyroidism in a Patient With Leukemic Infiltration of the Thyroid as the First Presentation of Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 May 29. doi: 10.1097/MPH.0000000000000869.
    PubMed     Text format     Abstract available


  30. GOPAKUMAR KG, Thankamony P, Nampoothiri S, Bali D, et al
    Wolman Disease: A Mimic of Infant Leukemia.
    J Pediatr Hematol Oncol. 2017 May 23. doi: 10.1097/MPH.0000000000000861.
    PubMed     Text format     Abstract available


  31. FUKANO R, Sunami S, Sekimizu M, Takimoto T, et al
    Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
    J Pediatr Hematol Oncol. 2017 May 22. doi: 10.1097/MPH.0000000000000850.
    PubMed     Text format     Abstract available


  32. BENITEZ LL, Gharibian K, Frame D, Mody R, et al
    Clofarabine Dosing in a Patient With Acute Myeloid Leukemia on Intermittent Hemodialysis: Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2017 May 22. doi: 10.1097/MPH.0000000000000845.
    PubMed     Text format     Abstract available


  33. JONES GL, McClellan W, Raman S, Sherman A, et al
    Parental Perceptions of Obesity and Obesity Risk Associated With Childhood Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 May 22. doi: 10.1097/MPH.0000000000000852.
    PubMed     Text format     Abstract available


  34. RAO Y, Wu Y, Dong A, Zhu K, et al
    Disseminated Nonleukemic Myeloid Sarcoma of the Spleen With Involvement of the Liver in an Infant.
    J Pediatr Hematol Oncol. 2017;39:e233-e235.
    PubMed     Text format     Abstract available


    April 2017
  35. SCHLOEMER NJ, Brickler M, Hoffmann R, Pan A, et al
    Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes.
    J Pediatr Hematol Oncol. 2017 Apr 27. doi: 10.1097/MPH.0000000000000838.
    PubMed     Text format     Abstract available


    March 2017
  36. BEN MAHMOUD L, Mdhaffar M, Ghozzi H, Ammar M, et al
    Oxidative Stress in Tunisian Patients With Acute Lymphoblastic Leukemia and Its Involvement in Leukemic Relapse.
    J Pediatr Hematol Oncol. 2017 Mar 16. doi: 10.1097/MPH.0000000000000793.
    PubMed     Text format     Abstract available


  37. ARIKAN K, Ozsurekci Y, Ceyhan M
    Bullous Pyoderma Gangrenosum as the Presenting Sign of Acute Myeloid Leukemia in a Child.
    J Pediatr Hematol Oncol. 2017 Mar 6. doi: 10.1097/MPH.0000000000000796.
    PubMed     Text format    


  38. ARIKAN K, Ozsurekci Y, Ceyhan M
    Bullous Pyoderma Gangrenosum as the Presenting Sign of Acute Myeloid Leukemia in a Child.
    J Pediatr Hematol Oncol. 2017 Mar 6. doi: 10.1097/MPH.0000000000000795.
    PubMed     Text format    


  39. BORGES ML, Capela de Matos RR, Amaral BD, Soares-Ventura EM, et al
    Molecular Cytogenetic Approach to Characterize Novel and Cryptic Chromosome Abnormalities in Childhood Myeloid Malignances of Fanconi Anemia.
    J Pediatr Hematol Oncol. 2017;39:e85-e91.
    PubMed     Text format     Abstract available


  40. FRAINT E, Miller R, Walter A
    Posterior Reversible Encephalopathy Syndrome and Cerebral Sinus Thrombosis in a Case of Pediatric B-Cell ALL.
    J Pediatr Hematol Oncol. 2017;39:e71-e73.
    PubMed     Text format     Abstract available


    February 2017
  41. NAZIR HF, Elshinawy M, AlRawas A, Khater D, et al
    Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000804.
    PubMed     Text format     Abstract available


  42. AL OMAR S, Anabtawi N, Al Qasem W, Rihani R, et al
    Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000792.
    PubMed     Text format     Abstract available


  43. DEMIRSOY U, Sarper N, Aylan Gelen S, Zengin E, et al
    The Association of Oral Vitamin D and Calcium Supplementation With Bone Mineral Density in Pediatric Acute Lymphoblastic Leukemia Patients.
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000797.
    PubMed     Text format     Abstract available


  44. HORIBE K, Yumura-Yagi K, Kudoh T, Nishimura S, et al
    Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
    J Pediatr Hematol Oncol. 2017 Feb 6. doi: 10.1097/MPH.0000000000000760.
    PubMed     Text format     Abstract available


    January 2017
  45. MCNERNEY KO, Vasquez JC, Kent MW, McNamara JM, et al
    Sinusoidal Obstruction Syndrome During Maintenance Therapy for Acute Lymphoblastic Leukemia With 6-Mercaptopurine and Methotrexate: A Pediatric Case Report.
    J Pediatr Hematol Oncol. 2017 Jan 12. doi: 10.1097/MPH.0000000000000776.
    PubMed     Text format     Abstract available


  46. DUJUA AC, Hernandez FG
    Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009:
    J Pediatr Hematol Oncol. 2017 Jan 12. doi: 10.1097/MPH.0000000000000751.
    PubMed     Text format     Abstract available


  47. KODURU PR, Wilson K, Wen J, Garcia R, et al
    Cytogenetic and Cytogenomic Microarray Characterization of Chromothripsis in Chromosome 8 Affecting MOZ/NCOA2 (TIF2), FGFR1, RUNX1T1, and RUNX1 in a Pediatric Acute Myeloid Leukemia.
    J Pediatr Hematol Oncol. 2017 Jan 12. doi: 10.1097/MPH.0000000000000770.
    PubMed     Text format     Abstract available


  48. VIOLA A, Balsamo L, Neglia JP, Brouwers P, et al
    The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.
    J Pediatr Hematol Oncol. 2017 Jan 12. doi: 10.1097/MPH.0000000000000761.
    PubMed     Text format     Abstract available


  49. JANCZAR S, Zalewska-Szewczyk B, Mlynarski W
    Severe Hyponatremia in a Single-Center Series of 84 Homogenously Treated Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000758.
    PubMed     Text format     Abstract available


  50. RASHED WM, Zekri W, Awad M, Taha H, et al
    Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000699.
    PubMed     Text format     Abstract available


  51. EBBESEN MS, Nygaard U, Rosthoj S, Sorensen D, et al
    Hepatotoxicity During Maintenance Therapy and Prognosis in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000733.
    PubMed     Text format     Abstract available


  52. KASSAR O, Hammemi R, Ben Dhaou M, Kammoun S, et al
    Spontaneous Fracture and Migration of a Totally Implanted Port Device to Pulmonary Artery in Acute Leukemia Child.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000734.
    PubMed     Text format     Abstract available


  53. CZOGALA M, Balwierz W, Sztefko K, Rogatko I, et al
    Antithrombin III as the Indicator of L-Asparaginase Activity in Children Treated for Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000739.
    PubMed     Text format     Abstract available


  54. HUANG JG, Yeoh AE, Tambyah PA, Suhaila MI, et al
    The Conundrum in the Diagnosis and Management of Atypical Fulminant Measles in a Leukemia Survivor on Maintenance Chemotherapy.
    J Pediatr Hematol Oncol. 2017;39:e36-e38.
    PubMed     Text format     Abstract available


  55. GRIMES A, Mirkheshti N, Chatterjee B, Tomlinson G, et al
    Paraneoplastic Galactorrhea in Childhood T-ALL: An Evaluation of Tumor-derived Prolactin.
    J Pediatr Hematol Oncol. 2017;39:e18-e20.
    PubMed     Text format     Abstract available


  56. FOSTER JH, Bernhardt MB, Thompson PA, Smith EO, et al
    Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity.
    J Pediatr Hematol Oncol. 2017;39:72-76.
    PubMed     Text format     Abstract available


    November 2016
  57. AL-SWEEDAN S, Al-Seraihy A, Al-Ahmari A, Al-Jefri A, et al
    Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  58. SCHULTZ KA, Chen L, Kunin-Batson A, Chen Z, et al
    Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  59. BRIERLEY CK, Revuelta Iniesta R, Storrar N, Thomas AE, et al
    Hyperferritinemia in Pediatric Acute Lymphoblastic Leukemia: What Does it Mean?
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


  60. VATSAYAN A, Gupta A, Ahuja S, Egler R, et al
    Epstein-Barr Virus-associated Mucocutaneous Ulcer in a Patient With T-Cell Acute Lymphoblastic Leukemia: Importance of Accurate Diagnosis and Conservative Management.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  61. JENSEN TS, Arendrup MC, von Buchvald C, Frandsen TL, et al
    Successful Treatment of Rhino-Orbital-Cerebral Mucormycosis in a Child With Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  62. PERKINS JL, Harris A, Pozos TC
    Immune Dysfunction After Completion of Childhood Leukemia Therapy.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  63. DAS A, Bansal D, Sreedharanunni S, Naseem S, et al
    Philadelphia Chromosome in an Infant With Pro-B Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


  64. ROBIN AJ, Peterson JF, Grignon JW Jr, Gheorghe G, et al
    Identification of High-risk Cryptic CRLF2 Rearrangements in B-Cell Acute Lymphoblastic Leukemia Utilizing an FGFR3/IGH Dual-Color Dual-Fusion DNA Probe Set.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  65. EL-FATTAH MA
    Survival Pattern of Chronic Myeloid Leukemia in a Pediatric Population in the United States.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


    August 2016
  66. LEVINSEN M, Harila-Saari A, Grell K, Jonsson OG, et al
    Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  67. BARDELLINI E, Amadori F, Schumacher RF, D'Ippolito C, et al
    Efficacy of a Solution Composed by Verbascoside, Polyvinylpyrrolidone (PVP) and Sodium Hyaluronate in the Treatment of Chemotherapy-induced Oral Mucositis in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  68. NAYIAGER T, Barr RD, Anderson L, Cranston A, et al
    Physical Activity in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: A Cross-sectional Cohort Study.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  69. OSONE S, Imamura T, Kanayama T, Tsuma Y, et al
    Sorafenib Therapy for Pediatric Acute Myeloid Leukemia with FMS-like Tyrosine Kinase 3-internal Tandem Duplication Mutations: 2 Case Reports.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  70. LYNGGAARD LS, Marquart HV, Kjeldsen E, Madsen HO, et al
    Acute Lymphoblastic Leukemia Presenting With Pancytopenia Followed by a 14-Month-Long Period of Transient Remission Possibly Supporting the Adrenal Hypothesis of Leukemogenesis.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  71. XIA M, Zhang H, Lu Z, Gao Y, et al
    Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016;38:418-22.
    PubMed     Text format     Abstract available


    July 2016
  72. JABEEN K, Ashraf MS, Iftikhar S, Belgaumi AF, et al
    The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC).
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  73. ELBAHLAWAN LM, Avent Y, Montoya L, Wilder K, et al
    Safety and Benefits of Bronchoalveolar Lavage and Lung Biopsy in the Management of Pulmonary Infiltrates in Children With Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  74. SHULMAN DS, Lee MA, Lehmann LE, Margossian SP, et al
    Outcomes Following Bone Marrow Transplantation in Children With Accelerated Phase or Blast Crisis Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  75. YEO KK, Gaynon PS, Fu CH, Wayne AS, et al
    Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance.
    J Pediatr Hematol Oncol. 2016;38:345-9.
    PubMed     Text format     Abstract available


    June 2016
  76. HONG D, Zhou C, He H, Wang Y, et al
    A 10-Year Follow-up Survey of Treatment Abandonment of Children With Acute Myeloid Leukemia in Suzhou, China.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  77. RODRIGUEZ V, Kairalla J, Salzer WL, Raetz EA, et al
    A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  78. VUNDAMATI D, Bostrom B
    Prolonged Response in Patient With Multiply Relapsed B-cell Acute Lymphoblastic Leukemia and Monosomy-7 to Bortezomib, Lenalidomide, and Dexamethasone.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  79. AL-EITAN LN, Rababa'h DM, Alkhatib RQ, Khasawneh RH, et al
    GSTM1 and GSTP1 Genetic Polymorphisms and Their Associations With Acute Lymphoblastic Leukemia Susceptibility in a Jordanian Population.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  80. ACHARYA S, Hsieh S, Shinohara ET, DeWees T, et al
    Effects of Race/Ethnicity and Socioeconomic Status on Outcome in Childhood Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  81. KOLENOVA A, Maloney KW, Hunger SP
    Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  82. BADAWY SM
    The Use of Hydroxyurea and Leukapheresis in Childhood Acute Leukemia With Hyperleukocytosis.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


    March 2016
  83. WEDEKIND MF, Dennis R, Sturm M, Koch T, et al
    The Effects of Hospital Length of Stay on Readmissions for Children With Newly Diagnosed Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  84. BROWN AL, Lupo PJ, Danysh HE, Okcu MF, et al
    Prevalence and Predictors of Overweight and Obesity Among a Multiethnic Population of Pediatric Acute Lymphoblastic Leukemia Survivors: A Cross-Sectional Assessment.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  85. SUN B, Li L, Xu M, Wang X, et al
    Significance of BAFF/APRIL Expression and Their Receptors in Pediatric Patients With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  86. ABLA O, Angelini P, Di Giuseppe G, Kanani MF, et al
    Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
    J Pediatr Hematol Oncol. 2016;38:111-7.
    PubMed     Text format     Abstract available


    February 2016
  87. MACDONALD T, Kulkarni K, Bernstein M, Fernandez CV, et al
    Allergic Reactions With Intravenous Compared With Intramuscular Pegaspargase in Children With High-risk Acute Lymphoblastic Leukemia: A Population-based Study From the Maritimes, Canada.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  88. RAMAMOORTHY J, Jain R, Trehan A, Saxena AK, et al
    Orbital Mass in a Child With Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  89. SMITHERMAN AB, Wilkins TM, Blatt J, Dusetzina SB, et al
    Early Posttherapy Hospitalizations Among Survivors of Childhood Leukemia and Lymphoma.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  90. TAVIL B, Isgandarova F, Bayhan T, Unal S, et al
    Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  91. BISS TT, Payne JH, Hough RE, Grainger JD, et al
    Strategies to Prevent and Manage Thrombotic Complications of Acute Lymphoblastic Leukemia in Children and Young People Vary Between Centers in the United Kingdom.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  92. HEFTI E, Blanco JG
    Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  93. BOUCHER MO, Smitherman AB, Pahl KS, Rao KW, et al
    RUNX1 Amplification Increases the Risk for Thrombosis in Children With B-cell Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  94. MONFRIES N, Belletrutti M, McKillop S
    Surgery as a Recurrent Trigger for Immune Thrombocytopenia (ITP) in a Patient Cured of M7 Acute Myelogenous Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  95. BERGMANN K, Hasle H, Asdahl P, Handrup MM, et al
    Central Venous Catheters and Bloodstream Infection During Induction Therapy in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  96. TAGIYEV A, Demirbilek H, Tavil B, Buyukyilmaz G, et al
    Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  97. TSEPIS K, Tragiannidis A, Gombakis N, Hatzistilianou M, et al
    Early-onset SMART Syndrome in an 11-Year-Old Child With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


    January 2016
  98. GIAMANCO NM, Cunningham BS, Klein LS, Parekh DS, et al
    Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  99. LAM GK, Leung AW, Ha SY, Luk CW, et al
    Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  100. WILLIAMS M, Khalid T, Hughes S, Bonney D, et al
    Rituximab-induced Cytokine Storm in the Absence of Overt Lymphoproliferative Disease.
    J Pediatr Hematol Oncol. 2016;38:e29-31.
    PubMed     Text format     Abstract available


  101. VUILLE-DIT-BILLE RN, Berger C, Meuli M, Grotzer MA, et al
    Colostomy for Perianal Sepsis With Ecthyma Gangrenosum in Immunocompromised Children.
    J Pediatr Hematol Oncol. 2016;38:53-7.
    PubMed     Text format     Abstract available


  102. ANDINA D, Lassaletta A, Sevilla J, Gutierrez S, et al
    Hemiparesis in an Adolescent With Acute Lymphoblastic Leukemia: Everything Is Not Always What it Seems.
    J Pediatr Hematol Oncol. 2016;38:63-4.
    PubMed     Text format     Abstract available


    October 2015
  103. DOMENECH C, Leick-Courtois C, Bienvenu AL, Pracros JP, et al
    Improvement in the Outcome of Invasive Aspergillosis in a Pediatric Hematology Department: A 10-Year Review.
    J Pediatr Hematol Oncol. 2015;37:560-5.
    PubMed     Text format     Abstract available


  104. YEUNG AK, Guilcher GM, deBruyn JC
    Conservative Management of Downhill Esophageal Varices Secondary to Central Line-related Thrombosis After Hematopoietic Stem Cell Transplant.
    J Pediatr Hematol Oncol. 2015;37:e424-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: